Applied DNA Ships COVID-19 LinearDNA™ Vaccine Candidates to Italian Development Partner to Begin Preclinical Animal Testing
Applied DNA Sciences, Inc. (APDN)
Last applied dna sciences, inc. earnings: 8/10 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
adnas.com/molecular-based-security/investors
Company Research
Source: Business Wire
- Preliminary Testing of Plasmid-based Vaccine Templates Shows Strong Immune Responses, Catalyzes Testing of Linear DNA-based Constructs Set to Begin Immediately -- RT-qPCR COVID-19 Diagnostic Gaining Promise - STONY BROOK, N.Y. & ROME--(BUSINESS WIRE)--Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”) a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that enables diagnostics, pre-clinical nucleic acid-based therapeutic drug candidates, supply chain security, anti-counterfeiting and anti-theft technology, today announced that it has completed design qualification, production and shipment of five COVID-19 vaccine candidates to Italy-based Takis Biotech (“Takis”), a developer of cancer vaccines and the Company’s COVID-19 vaccine development partner, to support preclinical animal testing that will begin immediately. The vaccine candidates were produced by the Company’s proprietary PCR-based LinearDNA™ manufacturing systems.“Preliminary animal
Show less
Read more
Impact Snapshot
Event Time:
APDN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
APDN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
APDN alerts
High impacting Applied DNA Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
APDN
News
- Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private PlacementAccesswire
- Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16 [Yahoo! Finance]Yahoo! Finance
- Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16Accesswire
- Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement Accesswire
- Applied DNA Sciences, Inc. (NASDAQ: APDN) was upgraded by analysts at StockNews.com to a "sell" rating.MarketBeat
APDN
Earnings
- 8/8/24 - Beat
APDN
Sec Filings
- 10/31/24 - Form 424B5
- 10/31/24 - Form 8-K
- 10/2/24 - Form SC
- APDN's page on the SEC website